These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

352 related items for PubMed ID: 17645585

  • 1. Endothelial dysfunction in insulin resistance and type 2 diabetes.
    Jansson PA.
    J Intern Med; 2007 Aug; 262(2):173-83. PubMed ID: 17645585
    [Abstract] [Full Text] [Related]

  • 2. Mechanisms of Disease: endothelial dysfunction in insulin resistance and diabetes.
    Rask-Madsen C, King GL.
    Nat Clin Pract Endocrinol Metab; 2007 Jan; 3(1):46-56. PubMed ID: 17179929
    [Abstract] [Full Text] [Related]

  • 3. Insulin resistance and endothelial dysfunction: the road map to cardiovascular diseases.
    Cersosimo E, DeFronzo RA.
    Diabetes Metab Res Rev; 2006 Jan; 22(6):423-36. PubMed ID: 16506274
    [Abstract] [Full Text] [Related]

  • 4. The endothelial dysfunction in diabetes mellitus.
    Pănuş C, Moţa M, Vladu D, Vanghelie L, Răducanu CL.
    Rom J Intern Med; 2003 Jan; 41(1):27-33. PubMed ID: 15529582
    [Abstract] [Full Text] [Related]

  • 5. Effects of insulin resistance on endothelial progenitor cells and vascular repair.
    Cubbon RM, Kahn MB, Wheatcroft SB.
    Clin Sci (Lond); 2009 Aug 03; 117(5):173-90. PubMed ID: 19630751
    [Abstract] [Full Text] [Related]

  • 6. Review article: diabetes and atherosclerosis--running on a common road.
    Federici M, Lauro R.
    Aliment Pharmacol Ther; 2005 Nov 03; 22 Suppl 2():11-5. PubMed ID: 16225464
    [Abstract] [Full Text] [Related]

  • 7. Hypoglycemic pharmacological treatment of type 2 diabetes: targeting the endothelium.
    Nathanson D, Nyström T.
    Mol Cell Endocrinol; 2009 Jan 15; 297(1-2):112-26. PubMed ID: 19038307
    [Abstract] [Full Text] [Related]

  • 8. Impaired endothelial function and insulin action in first-degree relatives of patients with type 2 diabetes mellitus.
    Sonne MP, Højbjerre L, Alibegovic AA, Vaag A, Stallknecht B, Dela F.
    Metabolism; 2009 Jan 15; 58(1):93-101. PubMed ID: 19059536
    [Abstract] [Full Text] [Related]

  • 9. Family history of diabetes is a major determinant of endothelial function.
    Goldfine AB, Beckman JA, Betensky RA, Devlin H, Hurley S, Varo N, Schonbeck U, Patti ME, Creager MA.
    J Am Coll Cardiol; 2006 Jun 20; 47(12):2456-61. PubMed ID: 16781373
    [Abstract] [Full Text] [Related]

  • 10. Insulin resistance and endothelial cell dysfunction: studies in mammalian models.
    Kearney MT, Duncan ER, Kahn M, Wheatcroft SB.
    Exp Physiol; 2008 Jan 20; 93(1):158-63. PubMed ID: 17933859
    [Abstract] [Full Text] [Related]

  • 11. Role of insulin resistance and hyperglycemia in the development of atherosclerosis.
    Bansilal S, Farkouh ME, Fuster V.
    Am J Cardiol; 2007 Feb 19; 99(4A):6B-14B. PubMed ID: 17307054
    [Abstract] [Full Text] [Related]

  • 12. Endothelial dysfunction and type 2 diabetes. Part 2: altered endothelial function and the effects of treatments in type 2 diabetes mellitus.
    Guerci B, Böhme P, Kearney-Schwartz A, Zannad F, Drouin P.
    Diabetes Metab; 2001 Sep 19; 27(4 Pt 1):436-47. PubMed ID: 11547217
    [Abstract] [Full Text] [Related]

  • 13. Endothelial dysfunction and diabetes: roles of hyperglycemia, impaired insulin signaling and obesity.
    Bakker W, Eringa EC, Sipkema P, van Hinsbergh VW.
    Cell Tissue Res; 2009 Jan 19; 335(1):165-89. PubMed ID: 18941783
    [Abstract] [Full Text] [Related]

  • 14. Endothelial dysfunction in obesity and insulin resistance: a road to diabetes and heart disease.
    Caballero AE.
    Obes Res; 2003 Nov 19; 11(11):1278-89. PubMed ID: 14627747
    [Abstract] [Full Text] [Related]

  • 15. Acute hyperglycemia and hyperinsulinemia enhance vasodilatation in Type 1 diabetes mellitus without increasing capillary permeability and inducing endothelial dysfunction.
    Oomen PH, Kant GD, Dullaart RP, Reitsma WD, Smit AJ.
    Microvasc Res; 2002 Jan 19; 63(1):1-9. PubMed ID: 11749067
    [Abstract] [Full Text] [Related]

  • 16. Hyperglycemia and hyperlipidemia are associated with endothelial dysfunction during the development of type 2 diabetes.
    Okon EB, Chung AW, Zhang H, Laher I, van Breemen C.
    Can J Physiol Pharmacol; 2007 May 19; 85(5):562-7. PubMed ID: 17632592
    [Abstract] [Full Text] [Related]

  • 17. Insulin resistance in skeletal muscle and adipose tissue in polycystic ovary syndrome: are the molecular mechanisms distinct from type 2 diabetes?
    Corbould A.
    Panminerva Med; 2008 Dec 19; 50(4):279-94. PubMed ID: 19078869
    [Abstract] [Full Text] [Related]

  • 18. Thiazolidinediones-improving endothelial function and potential long-term benefits on cardiovascular disease in subjects with type 2 diabetes.
    Dandona P, Ghanim H, Chaudhuri A, Mohanty P.
    J Diabetes Complications; 2008 Dec 19; 22(1):62-75. PubMed ID: 18191079
    [Abstract] [Full Text] [Related]

  • 19. Insulin resistance, metabolic syndrome and endothelial dysfunction.
    Bigazzi R, Bianchi S.
    J Nephrol; 2007 Dec 19; 20(1):10-4. PubMed ID: 17347967
    [Abstract] [Full Text] [Related]

  • 20. Obesity impairs vascular relaxation in human subjects: hyperglycemia exaggerates adrenergic vasoconstriction arterial dysfunction in obesity and diabetes.
    Sivitz WI, Wayson SM, Bayless ML, Sinkey CA, Haynes WG.
    J Diabetes Complications; 2007 Dec 19; 21(3):149-57. PubMed ID: 17493547
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 18.